Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma

NCT07699939 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

136

Enrollment

OTHER_GOV

Sponsor class

Conditions

Gastric Adenocarcinoma
Gastroesophageal Junction (GEJ) Adenocarcinoma

Interventions

DRUG: serplulimab
DRUG: Placebo

Sponsor

National Cancer Center, Japan